Intrinsiqs

Is Guardant Health, Inc. overvalued?

Guardant Health, Inc. (GH) — key valuation metrics and fundamentals.

No verdict
Price
$177.25
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$23.79B
Dividend yield
0.0%
Return on equity
211.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.